Sabra Healthcare REIT, Inc. $SBRA Stock Position Increased by Asset Planning Inc

Asset Planning Inc lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 8.0% during the second quarter, Holdings Channel reports. The institutional investor owned 20,176 shares of the real estate investment trust’s stock after buying an additional 1,500 shares during the quarter. Asset Planning Inc’s holdings in Sabra Healthcare REIT were worth $372,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. SVB Wealth LLC bought a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth $34,000. UMB Bank n.a. raised its position in shares of Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 1,621 shares during the period. Wealth Preservation Advisors LLC acquired a new stake in shares of Sabra Healthcare REIT during the first quarter worth $38,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after purchasing an additional 1,065 shares during the period. Finally, Anchor Investment Management LLC acquired a new stake in shares of Sabra Healthcare REIT during the first quarter worth $58,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Down 0.8%

NASDAQ:SBRA opened at $17.74 on Friday. The firm has a market capitalization of $4.25 billion, a price-to-earnings ratio of 23.34, a PEG ratio of 1.20 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The business’s fifty day moving average price is $18.76 and its 200 day moving average price is $18.17.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.8%. Sabra Healthcare REIT’s payout ratio is 157.89%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SBRA. Truist Financial boosted their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 27th. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, June 23rd. Cantor Fitzgerald began coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price on the stock. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and an average target price of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.